Fatty Acids in Airway Smooth Muscle of Asthmatics
Key facts
- Who runs it
- Brigham and Women's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- Nov 2026
- Expected to end
- Nov 2029
- Type of study
- Interventional
- Treatments tested
- coconut oil
- Record updated
- 23 October 2024
- Why it stopped
- Study never started
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Male and female participants, age 18 years and older at enrollment
- Never smokers or <10 pack year smoking history
- Body mass index (BMI) <25
- Clinical history consistent with asthma for >1 year
- No use of an inhaled corticosteroid in the prior 3mo
- Ability to perform reproducible spirometry according to ATS criteria
- Baseline Forced expiratory volume in 1 second (FEV1) ≥ 60% predicted
- Presence of bronchodilator reversibility, as defined by a minimum of 12% and ≥ 200 ml improvement after 4 puffs of albuterol, each 90 μg
- Ability to provide informed consent, as evidenced by signing a copy of the consent form approved by the Institutional Review Board
Who cannot take part
- Use of inhaled corticosteroid in the prior 3 mo
- Evidence that the participant may be non-adherent to medication regimen, or may move from the performance site area before trial completion
- History of smoking (cigarettes, cigars, pipes, marijuana or any other substances) within the past 1 year, or >10 pack-years total
- Medical contraindication to bronchoscopy/biopsy, i.e inability to stop aspirin, anticoagulant, or antiplatelet at any point during the study; coagulopathy; inability to lay flat; asthma exacerbation requiring corticosteroids in the preceding 4 weeks; history of adverse reaction or allergy to sedatives; history of difficult airway, or past difficulty with intubation
- Major medical problems prohibiting study participation, i.e presence of chronic or active lung disease other than asthma or history of unstable significant medical illness other than asthma
- Supplementation with fatty acids within the last 3 months
- BMI ≥25
- Pregnant or nursing
- Lack of bronchodilator response to 4 puffs of albuterol
Where in United States
- Asthma Research Center, Brigham and Women's HospitalBoston, United States
About the trial
What the trial wants to find out
In this proof of concept study, the investigators aim to determine if supplementation with coconut oil causes an increase in cholecystokinin and cholecystokinin receptor expression in the airway smooth muscle of lean asthmatics, and whether these changes correlate with changes in airway stiffness (estimated by bronchodilator reversibility, airway reactivity, and airway resistance) or symptom control.
Read full original descriptionShow less
The investigators propose a 5 week, single center trial in 20 lean patients with mild asthma (not taking inhaled corticosteroids) aged 18 and older. Subjects will supplement their usual diets with 3 tablespoons of coconut oil, a commercially available oil with high dodecanoic acid content, for 3 weeks. To quantify changes in airway smooth muscle cholecystokinin and cholecystokinin-receptor expression, each subject will undergo bronchoscopy with endobronchial biopsies before and after coconut oil ingestion.
For the secondary analysis, subjects will also complete spirometry with bronchodilator testing, methacholine challenge, body plethysmography, and an Asthma Control Questionnaire (ACQ) before and after the dietary intervention. This information will be used to compare the changes in airway smooth muscle cholecystokinin and cholecystokinin receptor expression to changes in bronchodilator reversibility, airway reactivity, airway resistance, and symptom control.
In the exploratory aims, the investigators will correlate the changes in airway smooth muscle cholecystokinin and cholecystokinin receptor expression with changes in FEV1 and peak flow measurements.
The investigators therefore hope to elucidate information about the mechanistic role of cholecystokinin in airway smooth muscle stiffness and contraction.
The group in the trial
- coconut oilTreatment being tested
Subjects will be instructed to supplement their diet with 3 tablespoons of coconut oil daily for three weeks.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Role of Cholecystokinin and the Cholecystokinin Receptor in the Airway Smooth Muscle of Asthmatics
- Record updated
- 23 October 2024